ID   OAS2_RAT                Reviewed;         733 AA.
AC   Q5MYU0;
DT   05-SEP-2012, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2005, sequence version 1.
DT   24-JAN-2024, entry version 87.
DE   RecName: Full=2'-5'-oligoadenylate synthase 2;
DE            Short=(2-5')oligo(A) synthase 2;
DE            Short=2-5A synthase 2;
DE            EC=2.7.7.84;
GN   Name=Oas2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Ovary;
RX   PubMed=17024523; DOI=10.1007/s00239-006-0073-3;
RA   Perelygin A.A., Zharkikh A.A., Scherbik S.V., Brinton M.A.;
RT   "The mammalian 2'-5' oligoadenylate synthetase gene family: evidence for
RT   concerted evolution of paralogous Oas1 genes in Rodentia and
RT   Artiodactyla.";
RL   J. Mol. Evol. 63:562-576(2006).
CC   -!- FUNCTION: Interferon-induced, dsRNA-activated antiviral enzyme which
CC       plays a critical role in cellular innate antiviral response. Activated
CC       by detection of double stranded RNA (dsRNA): polymerizes higher
CC       oligomers of 2'-5'-oligoadenylates (2-5A) from ATP which then bind to
CC       the inactive monomeric form of ribonuclease L (RNASEL) leading to its
CC       dimerization and subsequent activation. Activation of RNASEL leads to
CC       degradation of cellular as well as viral RNA, resulting in the
CC       inhibition of protein synthesis, thus terminating viral replication.
CC       Can mediate the antiviral effect via the classical RNASEL-dependent
CC       pathway or an alternative antiviral pathway independent of RNASEL. In
CC       addition, it may also play a role in other cellular processes such as
CC       apoptosis, cell growth, differentiation and gene regulation (By
CC       similarity). May act as a negative regulator of lactation, stopping
CC       lactation in virally infected mammary gland lobules, thereby preventing
CC       transmission of viruses to neonates (By similarity). Non-infected
CC       lobules would not be affected, allowing efficient pup feeding during
CC       infection (By similarity). {ECO:0000250|UniProtKB:E9Q9A9,
CC       ECO:0000250|UniProtKB:P29728}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3 ATP = 5'-triphosphoadenylyl-(2'->5')-adenylyl-(2'->5')-
CC         adenosine + 2 diphosphate; Xref=Rhea:RHEA:34407, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:67143; EC=2.7.7.84;
CC         Evidence={ECO:0000250|UniProtKB:P29728};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P29728};
CC   -!- ACTIVITY REGULATION: Produced as a latent enzyme which is activated by
CC       double stranded RNA (dsRNA) generated during the course of viral
CC       infection. The dsRNA activator must be at least 15 nucleotides long,
CC       and no modification of the 2'-hydroxyl group is tolerated. ssRNA or
CC       dsDNA do not act as activators. Strongly inhibited by copper, iron and
CC       zinc ions. Partially inhibited by cobalt and nickel ions.
CC       {ECO:0000250|UniProtKB:P29728}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:P29728}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P29728}.
CC       Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:P29728}.
CC   -!- PTM: Myristoylation is not essential for its activity.
CC       {ECO:0000250|UniProtKB:P29728}.
CC   -!- PTM: Glycosylated. Glycosylation is essential for its activity.
CC       {ECO:0000250|UniProtKB:P29728}.
CC   -!- SIMILARITY: Belongs to the 2-5A synthase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY230746; AAP57396.1; -; mRNA.
DR   RefSeq; NP_001009715.1; NM_001009715.1.
DR   AlphaFoldDB; Q5MYU0; -.
DR   SMR; Q5MYU0; -.
DR   STRING; 10116.ENSRNOP00000073899; -.
DR   iPTMnet; Q5MYU0; -.
DR   PhosphoSitePlus; Q5MYU0; -.
DR   PaxDb; 10116-ENSRNOP00000066845; -.
DR   GeneID; 363938; -.
DR   KEGG; rno:363938; -.
DR   AGR; RGD:1359697; -.
DR   CTD; 4939; -.
DR   RGD; 1359697; Oas2.
DR   eggNOG; ENOG502S649; Eukaryota.
DR   InParanoid; Q5MYU0; -.
DR   OrthoDB; 4638494at2759; -.
DR   PhylomeDB; Q5MYU0; -.
DR   PRO; PR:Q5MYU0; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0001730; F:2'-5'-oligoadenylate synthetase activity; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0003725; F:double-stranded RNA binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051607; P:defense response to virus; ISS:UniProtKB.
DR   GO; GO:0070106; P:interleukin-27-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; IBA:GO_Central.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; ISO:RGD.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:1903487; P:regulation of lactation; ISS:UniProtKB.
DR   GO; GO:0009617; P:response to bacterium; ISO:RGD.
DR   GO; GO:0009615; P:response to virus; TAS:UniProtKB.
DR   GO; GO:0006401; P:RNA catabolic process; ISO:RGD.
DR   GO; GO:0060337; P:type I interferon-mediated signaling pathway; ISS:UniProtKB.
DR   CDD; cd05400; NT_2-5OAS_ClassI-CCAase; 2.
DR   Gene3D; 1.10.1410.20; 2'-5'-oligoadenylate synthetase 1, domain 2; 2.
DR   Gene3D; 3.30.460.10; Beta Polymerase, domain 2; 2.
DR   InterPro; IPR018952; 2-5-oligoAdlate_synth_1_dom2/C.
DR   InterPro; IPR006117; 2-5OAS_C_CS.
DR   InterPro; IPR043518; 2-5OAS_N_CS.
DR   InterPro; IPR006116; NT_2-5OAS_ClassI-CCAase.
DR   InterPro; IPR043519; NT_sf.
DR   InterPro; IPR002934; Polymerase_NTP_transf_dom.
DR   PANTHER; PTHR11258:SF3; 2'-5'-OLIGOADENYLATE SYNTHASE 2; 1.
DR   PANTHER; PTHR11258; 2-5 OLIGOADENYLATE SYNTHETASE; 1.
DR   Pfam; PF01909; NTP_transf_2; 1.
DR   Pfam; PF10421; OAS1_C; 2.
DR   SUPFAM; SSF81301; Nucleotidyltransferase; 2.
DR   SUPFAM; SSF81631; PAP/OAS1 substrate-binding domain; 2.
DR   PROSITE; PS00832; 25A_SYNTH_1; 1.
DR   PROSITE; PS00833; 25A_SYNTH_2; 2.
DR   PROSITE; PS50152; 25A_SYNTH_3; 2.
PE   2: Evidence at transcript level;
KW   Acetylation; Antiviral defense; ATP-binding; Cytoplasm; Glycoprotein;
KW   Immunity; Innate immunity; Lipoprotein; Magnesium; Metal-binding;
KW   Myristate; Nucleotide-binding; Nucleotidyltransferase; Reference proteome;
KW   Repeat; RNA-binding; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P29728"
FT   CHAIN           2..733
FT                   /note="2'-5'-oligoadenylate synthase 2"
FT                   /id="PRO_0000418629"
FT   REGION          47..365
FT                   /note="OAS domain 1"
FT   REGION          373..713
FT                   /note="OAS domain 2"
FT   BINDING         427
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         439
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255"
FT   BINDING         441
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255"
FT   BINDING         510
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255"
FT   BINDING         574
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   BINDING         577
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P00973"
FT   MOD_RES         408
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P29728"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000250|UniProtKB:P29728"
SQ   SEQUENCE   733 AA;  84066 MW;  136B28AAE998544D CRC64;
     MGNWMPGWSS SGSLGVPPMP VQKLEKSVQV NLEPDEKCLS QTEVSSVPSQ KLEEYIQANL
     KPDEESLKQI DQAVDAISDL LCSEVMIDVL KVVKGGSYGR KTVLRDCSDG TLVLFTGLFK
     QFQDQKKYQD KLLDLIEQRL KSHEKYKKSV KRKLSLLEVQ VSIPGQSILL QLLPTFNPLC
     ISENPSAQVY QNLKRSMDQV KASPGEFSDC FTTLQQRFFE KYPGRLKDLI LLVKHWYKQL
     QDKWIIPSPP PLLYALELLT VYAWEQGCQT KDFDITQGIR TVLQLISQPT NLCVYWLDNY
     NFEDETVRNN LLHQLNSPRP VILDPTDPTN NVGKDDRFWQ LLAEEAQEWL NSLRLNKPHK
     PCWDVLPMPF FITPSHCLDK FIKDFLQPDK VFLNQIKRAV DIICSFLKET CFQNSDIKVL
     KIIKGGSTAK GTALQQRSDA DIIVFLSSLD SYDSLETERS QYVQEIRKQL EACQKAFNLG
     VKFDISKWMA PRVLSFTLES KSLKQSVEFD VLPAYDALGQ LRSDYTSRLK AYKKLIELYA
     SQDSLKGGEF SVCFTELQRD FIETRPTKLK GLIRLIKHWY KQCERKMKPK ASLPPKYALE
     LLTVYAWEHG SGTDGFDTAE GFRTVLDLVI RYRQLCVFWT VNYNFEEDHM RKFLLTQIQK
     KRPVILDPAD PTGDVGGGDR WCWHLLAKEA KEWLSSSCFQ VEPKSPVQPW KVPVVQTPGS
     CGAQIYPVVG GVY
//
